hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06295965, orgStudyIdInfo id: RG1123813, secondaryIdInfos id: NCI-2023-10315, type: REGISTRY, domain: CTRP (Clinical Trial Reporting Program), secondaryIdInfos id: FHIRB0020162, type: OTHER, domain: Fred Hutch/University of Washington Cancer Consortium, secondaryIdInfos id: R01CA272594, type: NIH, link: https://reporter.nih.gov/quickSearch/R01CA272594, briefTitle: Clonal Hematopoiesis in Ovarian Cancer Survivors and Risk of Secondary Blood Cancers, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-01-02, primaryCompletionDateStruct date: 2028-12-31, completionDateStruct date: 2031-12-31, studyFirstPostDateStruct date: 2024-03-06, lastUpdatePostDateStruct date: 2024-03-12, sponsorCollaboratorsModule leadSponsor name: University of Washington, class: OTHER, collaborators name: National Cancer Institute (NCI), descriptionModule briefSummary: This study is being done to investigate clonal hematopoiesis and therapy-emergent myeloid neoplasms in patients with ovarian cancers. Researchers want to identify risk factors for developing these blood cancers as well as if there is/are a genetic/environmental component(s) to developing blood cancer., conditionsModule conditions: Recurrent Fallopian Tube Carcinoma, conditions: Recurrent Ovarian Carcinoma, conditions: Recurrent Primary Peritoneal Carcinoma, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 2000, type: ESTIMATED, armsInterventionsModule interventions name: Non-Interventional Study, outcomesModule primaryOutcomes measure: Determine the correlation between baseline TP53m VAF in blood with CH expansion in OC patients, primaryOutcomes measure: Identify risk of TMN for OC survivors with and without TP53m CH treated with platinum chemotherapy and PARP inhibitors, primaryOutcomes measure: Define the trajectories of clonal evolution and mechanisms of transformation from non-cancerous TP53m to TMN, eligibilityModule sex: FEMALE, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Fred Hutch/University of Washington Cancer Consortium, status: RECRUITING, city: Seattle, state: Washington, zip: 98109, country: United States, contacts name: Swisher Lab Research Coordinators, role: CONTACT, phone: 206-616-8927, email: swisherlabrc@uw.edu, contacts name: Elizabeth Swisher, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 47.60621, lon: -122.33207, hasResults: False
protocolSection identificationModule nctId: NCT06295926, orgStudyIdInfo id: K5236, briefTitle: Serplulimab Combined With CCRT for LS-SCLC., statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-02-25, primaryCompletionDateStruct date: 2027-01-25, completionDateStruct date: 2027-12-31, studyFirstPostDateStruct date: 2024-03-06, lastUpdatePostDateStruct date: 2024-03-06, sponsorCollaboratorsModule leadSponsor name: Peking Union Medical College Hospital, class: OTHER, descriptionModule briefSummary: Small cell lung cancer(SCLC) has a poor prognosis and a relatively short overall survival time, urgently requiring innovative treatment strategies to improve the prognosis of such patients. Immunotherapy has become an important component of first-line therapy for extensive-stage small cell lung cancer (ES-SCLC). Studies have found that, compared to chemotherapy alone, the combination of Surlidumab with carboplatin and etoposide can extend the median overall survival in ES-SCLC to over 15 months. However, to date, research on the use of immunotherapy in combination with concurrent chemoradiotherapy (CCRT) in limited-stage small cell lung cancer (LS-SCLC) remains limited. This study aims to explore the clinical benefits of Surlidumab in combination with concurrent chemoradiotherapy in LS-SCLC and evaluate the safety of immunotherapy in combination with CCRT as first-line treatment for LS-SCLC. At the same time, it seeks to identify tumor-related biomarkers that can effectively predict the efficacy of immunotherapy and prognosis., conditionsModule conditions: Small Cell Lung Cancer, designModule studyType: INTERVENTIONAL, phases: PHASE2, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 96, type: ESTIMATED, armsInterventionsModule interventions name: Serplulimab, outcomesModule primaryOutcomes measure: Progression free survival, secondaryOutcomes measure: Overall survival, secondaryOutcomes measure: Incidence of adverse events graded according to National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) version 5.0, secondaryOutcomes measure: objective response rate (ORR), eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, city: Beijing, state: Beijing, zip: 100730, country: China, geoPoint lat: 39.9075, lon: 116.39723, hasResults: False
protocolSection identificationModule nctId: NCT06295900, orgStudyIdInfo id: 19.10.2023/63, briefTitle: The Effect of Aromatherapy Massage on Sleep Quality, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-01-05, primaryCompletionDateStruct date: 2024-12, completionDateStruct date: 2024-12, studyFirstPostDateStruct date: 2024-03-06, lastUpdatePostDateStruct date: 2024-03-06, sponsorCollaboratorsModule leadSponsor name: Nilgün Erdoğan, class: OTHER, descriptionModule briefSummary: Sleep disturbance is one of the most common complaints of patients admitted to ICU. Insufficient sleep in intensive care units may be associated with environmental reasons such as excessive light at night, loud warning sounds and mechanical ventilation alarms, as well as non-environmental factors, including the situation at the time of admission. Sleep assessment is subjective in nature, so it is difficult to perform in the ICU. Since communication with the patient is prevented, clear information about perceived rest and disturbing factors cannot be provided. For this reason, night rest is an issue that is often forgotten and ignored. This study applied a mixture of lavender, medicinal chamomile and neroli oil (in 20 ml of sweet almond oil; lavender oil 2 drops, medicinal chamomile 4 drops, neroli oil 6 drops) to patients who were monitored in intensive care on high-flow and oxygen, once a day for three days. This study will be conducted to determine the effect of aromatherapy massage applied for a total of 30 minutes on sleep quality., conditionsModule conditions: Diabetes Mellitus, conditions: Respiratory Failure, conditions: Pneumonia, conditions: Respiratory Disease, conditions: Stroke, Ischemic, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: It will be conducted as a randomized controlled single-blind study, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: NONE, enrollmentInfo count: 62, type: ESTIMATED, armsInterventionsModule interventions name: Intervention 1 Group, interventions name: Intervention 2 Group, interventions name: Placebo Control Group, outcomesModule primaryOutcomes measure: Patient Introduction Form, secondaryOutcomes measure: Patient Follow-up Form, otherOutcomes measure: Visual Comparison Sleep Scale, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Ömer Halisdemir University Training and Research Hospital, status: RECRUITING, city: Nigde, zip: 51100, country: Turkey, contacts name: nilgun erdogan, researcher, role: CONTACT, phone: 5312599220, email: nilgunerdogan37@gmail.com, geoPoint lat: 37.96583, lon: 34.67935, hasResults: False
protocolSection identificationModule nctId: NCT06295887, orgStudyIdInfo id: E-2402, briefTitle: Educational Efficacy of VR vs. Simulator in Emergency Medical Training, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-13, primaryCompletionDateStruct date: 2025-02-28, completionDateStruct date: 2025-12-31, studyFirstPostDateStruct date: 2024-03-06, lastUpdatePostDateStruct date: 2024-03-08, sponsorCollaboratorsModule leadSponsor name: Seoul National University Hospital, class: OTHER, collaborators name: Seoul National University, descriptionModule briefSummary: It has not been revealed which is more effective: an education program using virtual reality technology or a simulation education program using Sim-man.In this study, the participants are new doctors who graduated from medical school and started working as interns at hospitals. The participants were divided into two groups. One group received a training program using virtual reality technology, and the other group received simulation training using Sim-man. The investigators would like to compare the increase in confidence and satisfaction before and after training.After the classes and surveys are completed for each group, the participants will be able to receive other educational methods if they wish., conditionsModule conditions: Simulation Training, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: control group vs. test group, 1:1, primaryPurpose: OTHER, maskingInfo masking: NONE, enrollmentInfo count: 166, type: ESTIMATED, armsInterventionsModule interventions name: Educational Program using VR or simulator designed to improve medical intern's performance managing emergency situation, outcomesModule primaryOutcomes measure: self-rated confidence for managing emergency situation, primaryOutcomes measure: self-rated confidence for managing emergency situation, primaryOutcomes measure: performance in managing emergency situation, secondaryOutcomes measure: usability of Virtual Reality simulation program using User Experience Questionnaire Short, secondaryOutcomes measure: usability of Virtual Reality simulation program using Simulator Sickness Questionnaire, secondaryOutcomes measure: usability of Virtual Reality simulation program using System Usability Scale, eligibilityModule sex: ALL, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, hasResults: False
protocolSection identificationModule nctId: NCT06295874, orgStudyIdInfo id: 12.10.2022/50, briefTitle: The Effect of Aromatherapy Massage on Pain, Anxiety and Comfort, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-01-05, primaryCompletionDateStruct date: 2024-08-30, completionDateStruct date: 2024-08-30, studyFirstPostDateStruct date: 2024-03-06, lastUpdatePostDateStruct date: 2024-03-06, sponsorCollaboratorsModule leadSponsor name: Nilgün Erdoğan, class: OTHER, descriptionModule briefSummary: Patients in the intensive care unit (ICU) experience physical and psychological discomfort, including pain. Anxiety is a condition frequently encountered in the ICU. The hospital environment, especially the ICU, is reported as a significant cause of anxiety for patients. Comfort is a holistic, subjective and multidimensional concept that is affected by physical, environmental, social and psycho-spiritual contexts and changes over time and space. Comfort in intensive care is often associated with pain relief and end-of-life care. Assessment tools have been developed to measure patient comfort in the ICU, including levels of pain, delirium, and sedation. This work; Patients who are monitored in intensive care under high-flow and oxygen are treated with a mixture of lavender, thyme and eucalyptus oil (20 ml; lavender oil 5 drops, thyme oil 4 drops, eucalyptus oil 3 drops and 20 ml almond oil) twice a day for three days. This study was conducted to determine the effect of aromatherapy massage applied for a total of 30 minutes on some physiological parameters, pain, anxiety and intensive care comfort of the patients., conditionsModule conditions: Respiratory Insufficiency, conditions: Pulmonary Disease, Chronic Obstructive, conditions: Diabetes Mellitus, Type 2, conditions: High Blood Pressure, conditions: Stroke, Ischemic, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: randomized controlled single blind study, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: NONE, enrollmentInfo count: 61, type: ESTIMATED, armsInterventionsModule interventions name: Effect of aromatherapy massage on vital signs, pain, anxiety and comfort level, outcomesModule primaryOutcomes measure: Patient Introduction Form, secondaryOutcomes measure: Patient Follow-up Form, otherOutcomes measure: Drug Monitoring Form, otherOutcomes measure: Visual Pain Scale, otherOutcomes measure: Face Anxiety Scale, otherOutcomes measure: Comfort Rating Scale, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Ömer Halisdemir University Training and Research Hospital, status: RECRUITING, city: Nigde, zip: 51100, country: Turkey, contacts name: nilgun erdogan, researcher, role: CONTACT, phone: 5312599220, email: nilgunerdogan37@gmail.com, geoPoint lat: 37.96583, lon: 34.67935, hasResults: False
protocolSection identificationModule nctId: NCT06295861, orgStudyIdInfo id: 2023-1194, briefTitle: Prospective Cohort Study of Panvascular Disease, statusModule overallStatus: ACTIVE_NOT_RECRUITING, startDateStruct date: 2024-02-21, primaryCompletionDateStruct date: 2028-11-30, completionDateStruct date: 2028-12-31, studyFirstPostDateStruct date: 2024-03-06, lastUpdatePostDateStruct date: 2024-03-06, sponsorCollaboratorsModule leadSponsor name: Second Affiliated Hospital, School of Medicine, Zhejiang University, class: OTHER, descriptionModule briefSummary: To construct a comprehensive big data platform for Chinese people with panvascular disease, and establish a Chinese panvascular disease oriented to guide treatment decisions Cohort and imaging, biological database; According to the clinical features, morphological structure, pathological characteristics of panvascularization, vascular age As the core of the evaluation, a standard evaluation system and a risk prediction model of intervention technology suitable for the diagnosis and treatment of patients with panvascular disease in China were established. Into the Further optimize the treatment strategies, protocols and clinical pathways for panvascular disease to improve patient prognosis and promote its application., conditionsModule conditions: ASCVD, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 50000, type: ESTIMATED, armsInterventionsModule interventions name: no different intervention between the two cohort., outcomesModule primaryOutcomes measure: Cardiovascular adverse events, primaryOutcomes measure: Cardiovascular mortality, secondaryOutcomes measure: Rate of receiving vascular revascularization, secondaryOutcomes measure: Readmission rate for vascular reasons, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Department of Cardiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, city: Hangzhou, state: Zhejiang, zip: 310000, country: China, geoPoint lat: 30.29365, lon: 120.16142, locations facility: Second Affiliated Hospital, School of Medicine, Zhejiang University, city: Hangzhou, state: Zhejiang, zip: 310000, country: China, geoPoint lat: 30.29365, lon: 120.16142, hasResults: False
protocolSection identificationModule nctId: NCT06295848, orgStudyIdInfo id: KayseriCH005, briefTitle: The Effects of Cardiac Rehabilitation Programme in Hypertensive Rheumatoid Arthritis Patients, acronym: CARDIRA, statusModule overallStatus: RECRUITING, startDateStruct date: 2022-12-15, primaryCompletionDateStruct date: 2024-04-15, completionDateStruct date: 2024-06-15, studyFirstPostDateStruct date: 2024-03-06, lastUpdatePostDateStruct date: 2024-03-28, sponsorCollaboratorsModule leadSponsor name: Kayseri City Hospital, class: OTHER_GOV, descriptionModule briefSummary: The aim of this study is to investigate the beneficial impacts of the 6-week standardized CR program applied to hypertensive RA patients whose disease activity is under control with regular pharmacological treatment.Subjects will be randomly assigned to one of two groups: 1.) standard of care (SOC) treatment or 2.) SOC plus a 6 week CR program., conditionsModule conditions: Cardiac Rehabilitation, conditions: Rheumatoid Arthritis, conditions: Hypertension, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, enrollmentInfo count: 40, type: ESTIMATED, armsInterventionsModule interventions name: Exercise, outcomesModule primaryOutcomes measure: Framingham Risk Score(FRS), primaryOutcomes measure: QRISK-3 Risk Score, primaryOutcomes measure: 24-Hour Ambulatory Blood Pressure, primaryOutcomes measure: DAS28, primaryOutcomes measure: Maximal oxygen consumption (VO2max), secondaryOutcomes measure: The Six-Minute Walk Test (6MWT), secondaryOutcomes measure: The 36-Item Short Form Survey (SF-36), secondaryOutcomes measure: International Physical Activity Questionnaire (IPAQ) - Short Form, secondaryOutcomes measure: Beck Depression Inventory (BDI), eligibilityModule sex: ALL, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Health Sciences University, Kayseri Medicine Faculty, status: RECRUITING, city: Kayseri, state: Kocasinan, zip: 38080, country: Turkey, contacts name: HAVVA TALAY ÇALIŞ, PROFESSOR, role: CONTACT, phone: +905326874541, email: htalaycalis@yahoo.com, contacts name: PROFESSOR, role: CONTACT, geoPoint lat: 38.73222, lon: 35.48528, hasResults: False
protocolSection identificationModule nctId: NCT06295835, orgStudyIdInfo id: CS-2024-0001, briefTitle: Method Comparison Study for Measuring Potassium (K) and Ionized Calcium (iCa) in Blood, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05, primaryCompletionDateStruct date: 2024-09, completionDateStruct date: 2024-12, studyFirstPostDateStruct date: 2024-03-06, lastUpdatePostDateStruct date: 2024-03-22, sponsorCollaboratorsModule leadSponsor name: Abbott Point of Care, class: INDUSTRY, descriptionModule briefSummary: Method comparison study for Potassium (K) and ionized calcium (iCa)., conditionsModule conditions: Potassium (K) and Ionized Calcium (iCa) in Capillary Whole Blood, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, interventionModelDescription: Capillary whole blood specimens will be tested in duplicate on the i-STAT 1 Analyzer with the CG8+ cartridge and a blood analyte testing comparator device., primaryPurpose: DIAGNOSTIC, maskingInfo masking: NONE, enrollmentInfo count: 200, type: ESTIMATED, armsInterventionsModule interventions name: Fingerstick blood draw, outcomesModule primaryOutcomes measure: Performance comparison, primaryOutcomes measure: Performance comparison, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06295822, orgStudyIdInfo id: CMUH112-REC2-063, briefTitle: The Effectiveness of Chinese Medicine Nuan-gong-ye on Primary Dysmenorrhea, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-04, primaryCompletionDateStruct date: 2025-08-31, completionDateStruct date: 2026-02-28, studyFirstPostDateStruct date: 2024-03-06, lastUpdatePostDateStruct date: 2024-04-10, sponsorCollaboratorsModule leadSponsor name: China Medical University Hospital, class: OTHER, descriptionModule briefSummary: Primary dysmenorrhea is a common under-diagnosed complaint, with a prevalence of about 45-95% in women of childbearing age and about 10-25% in severe cases. Menstrual pain can be classified as primary or secondary. Primary menstrual pain is a crampy pain in the lower abdomen without any pelvic pathology, which usually occurs 6 to 12 months after the first menstruation. Primary menstrual pain is usually most severe on the first day of the menstrual cycle and lasts for 8 to 72 hours. The cause is still unknown, but studies suggest that it may be related to increased prostaglandins, which cause painful contractions of the uterus. The pain is often accompanied by other menstrual discomfort symptoms, including headache, breast tenderness, drowsiness, nausea, vomiting, constipation or diarrhea, and psychological anxiety, depression or irritability. In the case of secondary menstrual pain, there are clear pelvic pathologies, such as endometriosis, uterine fibroids, and pelvic inflammatory disease., conditionsModule conditions: Chinese Medicine, conditions: Primary Dysmenorrhea, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, enrollmentInfo count: 82, type: ESTIMATED, armsInterventionsModule interventions name: Nuan-gong-ye, interventions name: Placebo, outcomesModule primaryOutcomes measure: Visual Analogue Scale (VAS), secondaryOutcomes measure: Short Form McGill Pain Questionnaire (MPQ-SF), eligibilityModule sex: FEMALE, minimumAge: 20 Years, maximumAge: 40 Years, stdAges: ADULT, contactsLocationsModule locations facility: China Medical University Hospital, status: RECRUITING, city: Taichung, zip: 404, country: Taiwan, contacts name: HSUAN HSUAN WU, role: CONTACT, phone: +886928030693, email: whh900710@gmail.com, geoPoint lat: 24.1469, lon: 120.6839, hasResults: False